Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07824752

Effect of KA-EX Supplementation on Recovery Parameters in High-Level Young Football Players

The purpose of this study is to evaluate the effects of KA-EX supplementation on recovery parameters in elite young football players. Athletes from the Udine Primavera team will be randomly assigned to receive either the KA-EX supplement or a sensory-matched placebo immediately following their training sessions for a period of two months.

The researchers will monitor heart rate variability (HRV) and sleep quality using Garmin wearable devices, and assess changes in body composition using Dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA). The goal of the study is to determine if post-training KA-EX administration improves physiological recovery, sleep quality, and physical readiness in high-performance athletes during a competitive season.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

17 year–20 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Stadio BlueEnergy

Udine, Friuli Venecia, 3310', Italy

About this study

Background and Rationale: Post-exercise recovery is a critical determinant of performance and adaptation in high-level football players. Insufficient recovery can lead to decreased physical readiness and increased risk of injury. KA-EX is a nutritional supplement containing a complex of amino acids, electrolytes, and functional sugars designed to support metabolic and physiological recovery. This study aims to investigate its efficacy in a real-world elite training environment.

Study Objectives: The primary objective is to evaluate the effect of KA-EX supplementation on physiological recovery parameters (HRV). Secondary objectives include assessing the impact on sleep recovery indices, changes in body composition (via DEXA), and cellular health parameters (via BIA).

Methodology and Design: This is an experimental, randomized, double-blind, placebo-controlled study.

Participants: 25 male players from the Udine Primavera team (Italy). Intervention: Participants will be randomly assigned to an experimental group (KA-EX) or a control group (placebo). The products will be identical in appearance, taste, and packaging to ensure blinding.

Duration: The intervention will last for 2 months, typically following the pre-season period.

Procedures:

Baseline Assessment: Participants will undergo initial DEXA scans, bioelectrical impedance analysis (BIA 101), and anthropometric measurements. Monitoring with Garmin devices will be initiated.

Intervention Phase: Supplements or placebos will be administered immediately after every training session. Recovery variables (HRV and sleep) will be continuously monitored using Garmin algorithms.

Final Assessment: At the end of the 2-month period, DEXA, BIA, and anthropometric measurements will be repeated to evaluate longitudinal changes.

Statistical Analysis: Within-group and between-group differences will be analyzed to compare the magnitude of change from baseline to post-intervention. Temporal evolution of recovery metrics throughout the 8-week period will also be assessed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Membership of the Udine Primavera team at the time of the study. Regular participation in the training programme during the intervention period (September).

Provision of written informed consent to participate in the study. Willingness to use a Garmin wearable device for continuous monitoring of recovery variables.

Exclusion criteria

  • Presence of any injury or medical condition that limits normal participation in team training sessions.

Use of any other recovery supplements or ergogenic aids outside of the study protocol during the intervention period.

Failure to comply with the daily supplementation protocol or the scheduled assessment sessions (DEXA/BIA).

Treatment and study plan

KA-EX

Dietary Supplement

Powder sachet to be dissolved in water. Contains a patented complex of amino acids, electrolytes, and carbohydrates designed to normalize cortisol and support recovery.

Experimental: KA-EX Supplement

Dietary Supplement

Powder sachet with identical organoleptic characteristics but without the active recovery ingredients of KA-EX.

Primary outcomes

  1. Change from Baseline in Heart Rate Variability (rMSSD)

    Time frame: Baseline and daily for 8 weeks.

    Autonomic recovery assessed as Root Mean Square of Successive Differences (rMSSD) during nocturnal sleep via Garmin wearable devices. Higher values indicate better parasympathetic recovery.

Secondary outcomes

  1. Change from Baseline in Sleep Score

    Time frame: Daily for 8 weeks.

    Overall sleep quality score calculated by Garmin's proprietary algorithm based on sleep duration, REM, and deep sleep cycles.

  2. Change from Baseline in Recovery Readiness Index

    Time frame: Daily for 8 weeks.

    Daily readiness score (Body Battery) obtained via Garmin wearable algorithm. Scores range from 0 to 100; higher scores indicate greater physical readiness for training.

  3. Body Composition

    Time frame: 8 weeks.

    Body composition assessed at week 8. Lower values indicate reduction

Study contacts

Contact information is provided by the study sponsor or research team.

Francisco J. Berral de la Rosa, PhD

CONTACT

[email protected]

+34672781737

Sponsors and collaborators

Lead sponsor

Antonio Molina Lopez

Other

Collaborators

  • Universidad Europea de Madrid
  • Universidad Pablo de Olavide
  • University of Udine

Registry information

Official study title

Effect of KA-EX Supplementation on Recovery Parameters in High-Level Young Football Players: A Randomised, Double-Blind, Placebo-Controlled Study

Acronym: Effect of KA-E

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.